PDT

Vizient to Share Insights on Biosimilars at Festival of Biologics

Retrieved on: 
Monday, March 20, 2023

Vizient, Inc. announced today that Steven Lucio , PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, “Building the Sustainable Future of Biosimilars,” at the Festival of Biologics being held March 20-22 in San Diego.

Key Points: 
  • Vizient, Inc. announced today that Steven Lucio , PharmD, BCPS, senior principal, pharmacy solutions for Vizient, will share insights on biosimilars in the panel discussion, “Building the Sustainable Future of Biosimilars,” at the Festival of Biologics being held March 20-22 in San Diego.
  • Lucio, who has extensive expertise in biosimilars , educates healthcare organizations on the benefits of biosimilars and helps them develop strategies to include them in patient care.
  • Last year he led a team that conducted a survey of hospital leaders and pharmacy professionals from across the country that found biosimilars are gaining inclusion in hospital formularies, something long seen as a necessity for greater adoption.
  • “Vizient continues to advocate for biosimilar adoption to create more competition in the market,” Lucio said.

Laugh Factory to Celebrate Nowruz, the 3,000-Year-Old Persian New Year Tradition, on Monday, March 20

Retrieved on: 
Saturday, March 18, 2023

HOLLYWOOD, Calif., March 18, 2023 /PRNewswire/ -- Laugh Factory Hollywood is pleased to celebrate Nowruz, the Persian New Year, with a special performance on the Laugh Factory stage on Monday, March 20.

Key Points: 
  • HOLLYWOOD, Calif., March 18, 2023 /PRNewswire/ -- Laugh Factory Hollywood is pleased to celebrate Nowruz, the Persian New Year, with a special performance on the Laugh Factory stage on Monday, March 20.
  • Laugh Factory Hollywood will celebrate Nowruz, the Persian New Year, with a comedy show & fundraiser Monday, March 20
    Comedians will include Alonzo Bodden, Dan Ahdoot, Chris Bader, Maz Jobrani, Melissa Shoshahi, and more.
  • And of course, whoever attends the Nowruz show will receive an Iranian pastry, which is part of our tradition.
  • We are coming together to celebrate Nowruz, the 3,000-year-old Iranian New Year tradition for people of all faiths," said Laugh Factory owner Jamie Masada.

Cato Researchers to Demonstrate How to Stop "Living Off the Cloud" Attacks at RSAConference 2023

Retrieved on: 
Thursday, March 16, 2023

TEL AVIV, Israel, March 16, 2023 /PRNewswire/ -- Cato Networks, provider of the world's leading single-vendor SASE platform, announced today that Etay Maor, Cato's senior director of security strategy and adjunct professor at Boston College, and Avishay Zawoznik, security research manager at Cato, will demonstrate "Living Off the Cloud" (LOC) attacks and how CISOs can mitigate them in the prestigious "Hackers and Threats" track of the upcoming RSAConference™ 2023.

Key Points: 
  • With cloud applications becoming an integral part of an enterprise's network, cybercriminals are exploiting them for malicious actions.
  • The trust placed in sanctioned cloud applications allows the commands and file transfers used in attacks to bypass legacy security tools.
  • Find out from @CatoNetworks how to stop them at #catonetworks booth 5160 in Moscone North Expo at @RSAConference .
  • This is a new threat vector that needs sophisticated context-aware tools to identify and mitigate, as we are excited to explain and demonstrate at RSAConference 2023."

Cato Researchers to Demonstrate How to Stop "Living Off the Cloud" Attacks at RSAConference 2023

Retrieved on: 
Thursday, March 16, 2023

TEL AVIV, Israel, March 16, 2023 /PRNewswire/ -- Cato Networks, provider of the world's leading single-vendor SASE platform, announced today that Etay Maor, Cato's senior director of security strategy and adjunct professor at Boston College, and Avishay Zawoznik, security research manager at Cato, will demonstrate "Living Off the Cloud" (LOC) attacks and how CISOs can mitigate them in the prestigious "Hackers and Threats" track of the upcoming RSAConference™ 2023.

Key Points: 
  • With cloud applications becoming an integral part of an enterprise's network, cybercriminals are exploiting them for malicious actions.
  • The trust placed in sanctioned cloud applications allows the commands and file transfers used in attacks to bypass legacy security tools.
  • Find out from @CatoNetworks how to stop them at #catonetworks booth 5160 in Moscone North Expo at @RSAConference .
  • This is a new threat vector that needs sophisticated context-aware tools to identify and mitigate, as we are excited to explain and demonstrate at RSAConference 2023."

Cannabis Industry Webinar: Strategies to Survive and Thrive

Retrieved on: 
Wednesday, March 15, 2023

It's no secret that cannabis companies are struggling to manage their various growers, quality of strain types, and production capacity.

Key Points: 
  • It's no secret that cannabis companies are struggling to manage their various growers, quality of strain types, and production capacity.
  • Raj Badarinath , Chief Marketing and Product Officer at Rootstock Software, will moderate this discussion with the following cannabis industry panelists:
    “Today, the cannabis industry is at an inflection point with massive consolidation, supply chain inefficiency, legal ambiguity, and economic uncertainty,” said Badarinath.
  • “Cannabis companies want a cloud ERP that’s both flexible and mature enough to meet all their requirements and still support their competitive positioning.
  • Rootstock’s experienced panel will discuss strategies to optimize supply, automate processes, reduce costs, and maintain quality while adapting to ever-changing regulatory requirements.

Lattice Semiconductor to Host Analyst & Investor Day

Retrieved on: 
Wednesday, March 15, 2023

Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today opened registration for the livestream of its 2023 Analyst and Investor Day, which will be held on Monday, May 15, 2023 from 2-3:30 p.m. EDT / 11-12:30 p.m. PDT at the Nasdaq MarketSite in Times Square, New York City.

Key Points: 
  • Lattice Semiconductor Corporation (NASDAQ: LSCC), the low power programmable leader, today opened registration for the livestream of its 2023 Analyst and Investor Day, which will be held on Monday, May 15, 2023 from 2-3:30 p.m. EDT / 11-12:30 p.m. PDT at the Nasdaq MarketSite in Times Square, New York City.
  • During the event, Lattice’s management team will discuss the company’s expanded product portfolio and roadmap, long-term business strategy, and key growth opportunities.
  • Presentations followed by a live Q&A session will include:
    Advance registration for the event (virtual or in-person) is required on the company’s Investor Relations website ir.latticesemi.com through May 12, 2023 at 11 p.m. EDT / 8 p.m. PDT.
  • A replay of the event is expected to be available within 24 hours of its conclusion and for approximately one year thereafter.

SGH Announces Second Quarter Fiscal 2023 Financial Conference Call

Retrieved on: 
Tuesday, March 14, 2023

SMART Global Holdings, Inc. (“SGH” or the “Company”) (Nasdaq: SGH ) today announced that the company will host its quarterly financial conference call and webcast for its second quarter fiscal year 2023 earnings after market close on Tuesday, April 4, 2023, beginning at 1:30 p.m. Pacific Daylight Time (PDT) / 4:30 p.m. Eastern Daylight Time (EDT).

Key Points: 
  • SMART Global Holdings, Inc. (“SGH” or the “Company”) (Nasdaq: SGH ) today announced that the company will host its quarterly financial conference call and webcast for its second quarter fiscal year 2023 earnings after market close on Tuesday, April 4, 2023, beginning at 1:30 p.m. Pacific Daylight Time (PDT) / 4:30 p.m. Eastern Daylight Time (EDT).
  • Financial results will be issued in a press release prior to the conference call.
  • Webcast Information: To access the live webcast, visit: SGH Q2 FY23 Earnings Call Webcast
    Conference Call Information: Participants may also listen to the conference call by dialing): +1 833 470 1428 (domestic) or +1 929-526-1599 (international), using the access code 849109.
  • Replay Information: An archived version of the webcast will be available on the SGH investor relations website for one year after the webcast date at https://ir.sghcorp.com .

NyquistAI to Host Webinar on the Impact of Generative AI and ChatGPT on Life Sciences

Retrieved on: 
Wednesday, March 15, 2023

PALO ALTO, Calif., March 13, 2023 /PRNewswire/ -- NyquistAI announced today they will host a webinar on March 31 at 9 am PDT covering the very timely topic of the Impact of Generative AI and ChatGPT on Life Sciences. Two industry professionals will join NyquistAI's Co-founder and CEO, Michelle Wu to present the topic.

Key Points: 
  • NyquistAI, the world's largest platform covering all on-market drugs and medical technology that leverages the latest and smartest AI technology will host the webinar featuring industry leaders.
  • PALO ALTO, Calif., March 13, 2023 /PRNewswire/ -- NyquistAI announced today they will host a webinar on March 31 at 9 am PDT covering the very timely topic of the Impact of Generative AI and ChatGPT on Life Sciences.
  • "Many of us have been following the news on the development and advancements of Generative AI and ChatGPT.
  • "As we in the life sciences assess how this new technology and the capabilities it enables potentially can impact our industry, I'm happy to have Miguel Fierro and Sachin Choudhary join me to discuss some of the implications of Generative AI and ChatGPT for the life sciences industry."

Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate Update

Retrieved on: 
Wednesday, March 15, 2023

LOS ANGELES, March 15, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that it will host a conference call and live webcast on Tuesday, March 28, 2023 at 8:30 am EDT (5:30 am PDT) to report fourth quarter and full-year 2022 financial results and provide recent corporate updates.

Key Points: 
  • Company to Host Conference Call and Webcast on March 28, 2023
    LOS ANGELES, March 15, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that it will host a conference call and live webcast on Tuesday, March 28, 2023 at 8:30 am EDT (5:30 am PDT) to report fourth quarter and full-year 2022 financial results and provide recent corporate updates.
  • Participants may access a live webcast of the call on the "Investors & News" page of the Aadi Bioscience website at aadibio.com .
  • To participate via telephone, please register in advance here: Conference Registration (vevent.com) .
  • A replay of the conference call and webcast will be archived on the website for at least 30 days.

Berkshire Biomedical to Present at the LSI USA '23 Emerging Medtech Summit

Retrieved on: 
Tuesday, March 14, 2023

DALLAS, March 14, 2023 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, announced today that John Timberlake, Chief Executive Officer, will present at the fourth annual Life Science Intelligence (LSI) USA '23 Emerging Medtech Summit on March 22, 2023, at 10:55 am PDT.

Key Points: 
  • DALLAS, March 14, 2023 /PRNewswire/ -- Berkshire Biomedical Corporation ("Berkshire" or the "Company"), focused on developing its proprietary drug dispensing technology to enhance patient wellness, announced today that John Timberlake, Chief Executive Officer, will present at the fourth annual Life Science Intelligence (LSI) USA '23 Emerging Medtech Summit on March 22, 2023, at 10:55 am PDT.
  • "Presenting at the LSI Emerging Medtech Summit provides an opportunity to showcase our proprietary, cloud-based, physician-enabled COPA device and the Company's initial focus on utilizing our technology to help more patients with Opioid Use Disorder gain access to take-home therapy," stated Mr. Timberlake.
  • We look forward to sharing the considerable progress the Company has made advancing the development of our COPA technology in preparation for filing a De Novo application with the FDA later this year."
  • Those attending the Emerging Medtech Summit who are interested in scheduling a one-on-one meeting with management, can utilize the meeting portal or can contact Michael Miller at [email protected] .